Zilver® PTX® Drug-Eluting Peripheral Stent From Cook Medical Qualifies for Additional Medicare Reimbursement

Published: Aug 27, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Effective October 1, Cook Medical’s Zilver® PTX® Drug-Eluting Peripheral Stent qualifies for new-technology add-on payments under Medicare’s hospital inpatient prospective payment system.

Help employers find you! Check out all the jobs and post your resume.

Back to news